id	sid	eid	entity	type
fnp-3049	1	1	1:33	CARDINAL
fnp-3049	1	2	2020	DATE
fnp-3049	1	3	liza bergkvist1	PERSON
fnp-3049	1	4	#	CARDINAL
fnp-3049	1	5	george1	PERSON
fnp-3049	1	6	michaela johnson1	PERSON
fnp-3049	1	7	meyerdirk1	PERSON
fnp-3049	1	8	emily schulz1	PERSON
fnp-3049	1	9	jennifer a. steiner1	PERSON
fnp-3049	1	10	zachary madaj3	PERSON
fnp-3049	1	11	jiyan ma1	PERSON
fnp-3049	1	12	becker1	PERSON
fnp-3049	1	13	k. peter r. nilsson4	PERSON
fnp-3049	1	14	jerry r. colca5	PERSON
fnp-3049	1	15	patrik brundin1 1	PERSON
fnp-3049	1	16	van andel institute	ORG
fnp-3049	1	17	grand rapids	GPE
fnp-3049	1	18	mi, usa	ORG
fnp-3049	1	19	2 ku leuven	QUANTITY
fnp-3049	1	20	belgium	GPE
fnp-3049	2	1	3	CARDINAL
fnp-3049	2	2	van andel institute	ORG
fnp-3049	2	3	grand rapids	GPE
fnp-3049	2	4	mi, usa	ORG
fnp-3049	2	5	4	CARDINAL
fnp-3049	2	6	sweden	GPE
fnp-3049	2	7	5	CARDINAL
fnp-3049	2	8	kalamazoo	GPE
fnp-3049	2	9	mi, usa	ORG
fnp-3049	2	10	#	CARDINAL
fnp-3049	3	1	karolinska institute	ORG
fnp-3049	3	2	stockholm	GPE
fnp-3049	3	3	sweden	GPE
fnp-3049	5	1	patrik brundin	PERSON
fnp-3049	5	2	van andel institute · grand rapids	ORG
fnp-3049	5	3	mi · usa patrik.brundin@vai.org	ORG
fnp-3049	5	4	01 october 2020	DATE
fnp-3049	5	5	21	CARDINAL
fnp-3049	5	6	november 2020	DATE
fnp-3049	5	7	jerry j. lou	PERSON
fnp-3049	6	1	25	CARDINAL
fnp-3049	6	2	november 2020 https://doi.org/10.17879/freeneuropathology-2020-3049	DATE
fnp-3049	8	1	msdc-0160	DATE
fnp-3049	8	2	pd	GPE
fnp-3049	10	1	pd	GPE
fnp-3049	11	1	two	CARDINAL
fnp-3049	11	2	msdc-0160	DATE
fnp-3049	12	1	two	CARDINAL
fnp-3049	14	1	msdc-0160	DATE
fnp-3049	17	1	lewy bodies	ORG
fnp-3049	17	2	msa	ORG
fnp-3049	17	3	symptoms1	PERSON
fnp-3049	18	1	elsewhere2	EVENT
fnp-3049	19	1	2	CARDINAL
fnp-3049	19	2	diabetes3-5	LAW
fnp-3049	19	3	2	CARDINAL
fnp-3049	19	4	38%	PERCENT
fnp-3049	20	1	2	CARDINAL
fnp-3049	20	2	resistance5	PERSON
fnp-3049	22	1	1	CARDINAL
fnp-3049	22	2	glp1)-agonist	NORP
fnp-3049	23	1	weekly	DATE
fnp-3049	23	2	48 weeks	DATE
fnp-3049	23	3	12-week	DATE
fnp-3049	23	4	period6	GPE
fnp-3049	24	1	treatment7	LOC
fnp-3049	25	1	200	CARDINAL
fnp-3049	25	2	2 years	DATE
fnp-3049	26	1	second	ORDINAL
fnp-3049	27	1	2	CARDINAL
fnp-3049	27	2	iii)8	ORG
fnp-3049	30	1	msdc-0160	DATE
fnp-3049	31	1	msdc-0160	DATE
fnp-3049	32	1	mpc)9	NORP
fnp-3049	33	1	pd	GPE
fnp-3049	33	2	msdc-0160	DATE
fnp-3049	33	3	msdc-0160	DATE
fnp-3049	33	4	neuroprotective10	GPE
fnp-3049	34	1	msdc-0160	DATE
fnp-3049	34	2	engrailed 1	CARDINAL
fnp-3049	34	3	en1	NORP
fnp-3049	35	1	msdc-0160	DATE
fnp-3049	36	1	msdc-0160	DATE
fnp-3049	37	1	msdc-0160	DATE
fnp-3049	38	1	msdc-0160	DATE
fnp-3049	38	2	two	CARDINAL
fnp-3049	38	3	1	CARDINAL
fnp-3049	38	4	2	CARDINAL
fnp-3049	39	1	msdc-0160	DATE
fnp-3049	40	1	msdc-0160	DATE
fnp-3049	40	2	five weeks	DATE
fnp-3049	40	3	13-week	DATE
fnp-3049	42	1	msdc-0160	DATE
fnp-3049	43	1	twelve-week-old	DATE
fnp-3049	43	2	c57bl/6j	ORG
fnp-3049	43	3	jackson	GPE
fnp-3049	44	1	eight-week old	DATE
fnp-3049	44	2	charles river	GPE
fnp-3049	45	1	four	CARDINAL
fnp-3049	45	2	two	CARDINAL
fnp-3049	45	3	12	CARDINAL
fnp-3049	46	1	msdc-0160	DATE
fnp-3049	46	2	msdc-0160	DATE
fnp-3049	46	3	3 days	DATE
fnp-3049	46	4	30mg/kg	QUANTITY
fnp-3049	47	1	day 3	DATE
fnp-3049	48	1	msdc-0160	DATE
fnp-3049	48	2	msdc-0160	DATE
fnp-3049	48	3	30 mg/kg	QUANTITY
fnp-3049	48	4	1 week	DATE
fnp-3049	49	1	two	CARDINAL
fnp-3049	49	2	one	CARDINAL
fnp-3049	49	3	three months	DATE
fnp-3049	49	4	pbs/pff injections	ORG
fnp-3049	50	1	four months	DATE
fnp-3049	51	1	united states national institutes of health	ORG
fnp-3049	51	2	the van andel research institute's	ORG
fnp-3049	52	1	mouse αsyn	PERSON
fnp-3049	52	2	previously12	PERSON
fnp-3049	53	1	four min	DATE
fnp-3049	53	2	q700	GPE
fnp-3049	53	3	50%	PERCENT
fnp-3049	53	4	120	CARDINAL
fnp-3049	53	5	1	CARDINAL
fnp-3049	53	6	1	CARDINAL
fnp-3049	54	1	0.8	CARDINAL
fnp-3049	54	2	18	CARDINAL
fnp-3049	54	3	0.8	CARDINAL
fnp-3049	54	4	pbs	ORG
fnp-3049	54	5	18	CARDINAL
fnp-3049	55	1	+ 5.4 mm	QUANTITY
fnp-3049	55	2	1.0 mm	QUANTITY
fnp-3049	55	3	dura	GPE
fnp-3049	56	1	0.2	CARDINAL
fnp-3049	56	2	10	CARDINAL
fnp-3049	56	3	hamilton	PERSON
fnp-3049	57	1	three min	DATE
fnp-3049	59	1	two	CARDINAL
fnp-3049	59	2	sn	ORG
fnp-3049	61	1	2.5x1011gc	CARDINAL
fnp-3049	62	1	3x1011gc	CARDINAL
fnp-3049	62	2	pbs	ORG
fnp-3049	63	1	5.3 mm	QUANTITY
fnp-3049	63	2	7.2 mm	QUANTITY
fnp-3049	64	1	3	CARDINAL
fnp-3049	64	2	0.25	CARDINAL
fnp-3049	64	3	30	CARDINAL
fnp-3049	64	4	10	CARDINAL
fnp-3049	64	5	hamilton	PERSON
fnp-3049	65	1	msdc-0160	DATE
fnp-3049	65	2	msdc-0160	DATE
fnp-3049	65	3	30 mg/kg	QUANTITY
fnp-3049	65	4	up to four months	DATE
fnp-3049	66	1	five and 13 weeks	DATE
fnp-3049	66	2	6 ml	QUANTITY
fnp-3049	67	1	four months	DATE
fnp-3049	68	1	15 min	TIME
fnp-3049	68	2	4°	QUANTITY
fnp-3049	68	3	2000	DATE
fnp-3049	68	4	-80°	QUANTITY
fnp-3049	69	1	225 mm	QUANTITY
fnp-3049	69	2	6 mm k2hpo4	QUANTITY
fnp-3049	69	3	5 mm mgcl2	QUANTITY
fnp-3049	69	4	20 mm kcl	QUANTITY
fnp-3049	69	5	2 mm egta	QUANTITY
fnp-3049	70	1	750	CARDINAL
fnp-3049	70	2	second	ORDINAL
fnp-3049	70	3	15,800	CARDINAL
fnp-3049	71	1	charles river laboratories	ORG
fnp-3049	71	2	msdc-0160	DATE
fnp-3049	71	3	1443	CARDINAL
fnp-3049	72	1	25	CARDINAL
fnp-3049	72	2	qc	ORG
fnp-3049	72	3	10	CARDINAL
fnp-3049	72	4	1,250 ng/ml	QUANTITY
fnp-3049	73	1	50/50	CARDINAL
fnp-3049	73	2	140	CARDINAL
fnp-3049	74	1	1.0 ml	QUANTITY
fnp-3049	75	1	100	CARDINAL
fnp-3049	75	2	100	CARDINAL
fnp-3049	75	3	5 mm	QUANTITY
fnp-3049	76	1	96	CARDINAL
fnp-3049	78	1	3	CARDINAL
fnp-3049	78	2	2.1 x	QUANTITY
fnp-3049	78	3	50 mm	QUANTITY
fnp-3049	78	4	3 μm	CARDINAL
fnp-3049	78	5	5 mm	QUANTITY
fnp-3049	78	6	75/25	CARDINAL
fnp-3049	78	7	5 mm	QUANTITY
fnp-3049	78	8	72/18/10	CARDINAL
fnp-3049	78	9	500	CARDINAL
fnp-3049	79	1	5000	CARDINAL
fnp-3049	80	1	msdc-0160	DATE
fnp-3049	80	2	msdc-0037	PERSON
fnp-3049	80	3	studies15	LOC
fnp-3049	81	1	(130 mg/kg	QUANTITY
fnp-3049	81	2	pbs	ORG
fnp-3049	83	1	-80°	QUANTITY
fnp-3049	84	1	pbs	ORG
fnp-3049	84	2	10%	PERCENT
fnp-3049	85	1	4°	QUANTITY
fnp-3049	85	2	2	CARDINAL
fnp-3049	85	3	15	CARDINAL
fnp-3049	85	4	0.5	CARDINAL
fnp-3049	85	5	10%	PERCENT
fnp-3049	86	1	10 min	TIME
fnp-3049	86	2	6000 x	QUANTITY
fnp-3049	86	3	4°	QUANTITY
fnp-3049	88	1	20%	PERCENT
fnp-3049	88	2	1%	PERCENT
fnp-3049	88	3	pbs	ORG
fnp-3049	88	4	1	CARDINAL
fnp-3049	89	1	10 min	TIME
fnp-3049	89	2	6000 x	QUANTITY
fnp-3049	89	3	4°	QUANTITY
fnp-3049	90	1	100,000 x	QUANTITY
fnp-3049	90	2	60 min	TIME
fnp-3049	90	3	pbs	ORG
fnp-3049	90	4	1%	PERCENT
fnp-3049	90	5	pbs	ORG
fnp-3049	91	1	second	ORDINAL
fnp-3049	91	2	100,000 x	QUANTITY
fnp-3049	91	3	10 min	TIME
fnp-3049	91	4	1%	PERCENT
fnp-3049	92	1	fisher	ORG
fnp-3049	93	1	2%	PERCENT
fnp-3049	93	2	95°	QUANTITY
fnp-3049	93	3	10 min	TIME
fnp-3049	93	4	-80°	QUANTITY
fnp-3049	94	1	4-15%	PERCENT
fnp-3049	95	1	5%	PERCENT
fnp-3049	95	2	bsa	ORG
fnp-3049	95	3	pbs	ORG
fnp-3049	95	4	30 min	TIME
fnp-3049	96	1	overnight	TIME
fnp-3049	96	2	1:500	CARDINAL
fnp-3049	96	3	ps129	PERSON
fnp-3049	96	4	lamp1	PERSON
fnp-3049	96	5	1:500	CARDINAL
fnp-3049	97	1	fisher	ORG
fnp-3049	100	1	30	CARDINAL
fnp-3049	102	1	around 50%	PERCENT
fnp-3049	103	1	johnson	PERSON
fnp-3049	103	2	overnight	TIME
fnp-3049	103	3	three days	DATE
fnp-3049	104	1	more than 10%	PERCENT
fnp-3049	105	1	the first day	DATE
fnp-3049	105	2	bio-serv	PERSON
fnp-3049	107	1	four consecutive days	DATE
fnp-3049	107	2	1 cm	QUANTITY
fnp-3049	108	1	300	CARDINAL
fnp-3049	108	2	300	CARDINAL
fnp-3049	109	1	nine	CARDINAL
fnp-3049	109	2	ten	CARDINAL
fnp-3049	110	1	60 mg/ml	QUANTITY
fnp-3049	110	2	0.9%	PERCENT
fnp-3049	110	3	4%	PERCENT
fnp-3049	110	4	0.1	CARDINAL
fnp-3049	111	1	4°	QUANTITY
fnp-3049	111	2	4%	PERCENT
fnp-3049	111	3	30%	PERCENT
fnp-3049	112	1	40 μm	CARDINAL
fnp-3049	112	2	leica	PERSON
fnp-3049	113	1	ab51253	GPE
fnp-3049	113	2	fisher	ORG
fnp-3049	113	3	35-8300	CARDINAL
fnp-3049	113	4	1:800	CARDINAL
fnp-3049	113	5	019-19741	CARDINAL
fnp-3049	114	1	sn	ORG
fnp-3049	114	2	ab51253	GPE
fnp-3049	114	3	fisher	ORG
fnp-3049	114	4	35-8300	CARDINAL
fnp-3049	114	5	1:800	CARDINAL
fnp-3049	114	6	019-19741	CARDINAL
fnp-3049	115	1	1:500	CARDINAL
fnp-3049	115	2	ba-1000	ORG
fnp-3049	116	1	abc kit	ORG
fnp-3049	118	1	neunand th-immunostained	ORG
fnp-3049	118	2	cv	ORG
fnp-3049	119	1	60 mounting	QUANTITY
fnp-3049	119	2	fisher	ORG
fnp-3049	120	1	lamp2	ORG
fnp-3049	120	2	anti-lamp2	NORP
fnp-3049	120	3	ab13524	PRODUCT
fnp-3049	120	4	overnight	TIME
fnp-3049	120	5	2	CARDINAL
fnp-3049	120	6	fisher	ORG
fnp-3049	120	7	alexa	ORG
fnp-3049	120	8	488	CARDINAL
fnp-3049	121	1	dapi	PERSON
fnp-3049	122	1	ab51253	GPE
fnp-3049	122	2	2h	CARDINAL
fnp-3049	122	3	1h	CARDINAL
fnp-3049	122	4	647	CARDINAL
fnp-3049	123	1	fisher	ORG
fnp-3049	124	1	0.5 μm	CARDINAL
fnp-3049	124	2	30 min	TIME
fnp-3049	124	3	rt.	ORG
fnp-3049	124	4	antifade	NORP
fnp-3049	125	1	nikon	ORG
fnp-3049	126	1	20x	CARDINAL
fnp-3049	126	2	axioscan	NORP
fnp-3049	126	3	0.22 μm	QUANTITY
fnp-3049	127	1	2d	CARDINAL
fnp-3049	128	1	20 μm	CARDINAL
fnp-3049	128	2	3 μm	CARDINAL
fnp-3049	129	1	85%	PERCENT
fnp-3049	130	1	helsinki	GPE
fnp-3049	130	2	finland	GPE
fnp-3049	131	1	cnn	ORG
fnp-3049	133	1	ninety-one	CARDINAL
fnp-3049	134	1	cnn	ORG
fnp-3049	135	1	first	ORDINAL
fnp-3049	136	1	second	ORDINAL
fnp-3049	137	1	cnn	ORG
fnp-3049	138	1	aon	GPE
fnp-3049	138	2	allen mouse	PERSON
fnp-3049	138	3	atlas	PERSON
fnp-3049	138	4	allen institute	ORG
fnp-3049	138	5	cnn	ORG
fnp-3049	140	1	one-month	DATE
fnp-3049	140	2	six	CARDINAL
fnp-3049	140	3	three-month	DATE
fnp-3049	140	4	seven to eight	CARDINAL
fnp-3049	142	1	αsyn	PERSON
fnp-3049	142	2	seven	CARDINAL
fnp-3049	142	3	six	CARDINAL
fnp-3049	142	4	40 μm	QUANTITY
fnp-3049	142	5	240 μm	QUANTITY
fnp-3049	143	1	10x	CARDINAL
fnp-3049	143	2	60x	CARDINAL
fnp-3049	143	3	200 μm	QUANTITY
fnp-3049	144	1	12 μm	QUANTITY
fnp-3049	144	2	3 μm	CARDINAL
fnp-3049	145	1	gunderson	PERSON
fnp-3049	145	2	less than 0.1	CARDINAL
fnp-3049	145	3	eight	CARDINAL
fnp-3049	146	1	the αsyn pff	ORG
fnp-3049	146	2	cv	ORG
fnp-3049	146	3	aon	GPE
fnp-3049	146	4	allen mouse	PERSON
fnp-3049	146	5	atlas	PERSON
fnp-3049	146	6	allen institute	ORG
fnp-3049	146	7	2.5x	CARDINAL
fnp-3049	147	1	cv	ORG
fnp-3049	147	2	240 μm	QUANTITY
fnp-3049	148	1	60x	CARDINAL
fnp-3049	148	2	200x200	CARDINAL
fnp-3049	148	3	40x40	CARDINAL
fnp-3049	149	1	10 μm	QUANTITY
fnp-3049	149	2	3 μm	CARDINAL
fnp-3049	150	1	gunderson	PERSON
fnp-3049	150	2	less than 0.1	CARDINAL
fnp-3049	150	3	nine	CARDINAL
fnp-3049	150	4	ten	CARDINAL
fnp-3049	152	1	60x	CARDINAL
fnp-3049	154	1	five	CARDINAL
fnp-3049	154	2	six	CARDINAL
fnp-3049	155	1	6th	ORDINAL
fnp-3049	155	2	aon	GPE
fnp-3049	155	3	30	CARDINAL
fnp-3049	156	1	lamp2	ORG
fnp-3049	156	2	aon	GPE
fnp-3049	156	3	20x	CARDINAL
fnp-3049	156	4	nikon	ORG
fnp-3049	157	1	lamp2	ORG
fnp-3049	159	1	six	CARDINAL
fnp-3049	160	1	aav	PRODUCT
fnp-3049	160	2	pff mouse	ORG
fnp-3049	160	3	two	CARDINAL
fnp-3049	160	4	0.05	CARDINAL
fnp-3049	160	5	benjamini-hochberg	PERSON
fnp-3049	161	1	iba1	GPE
fnp-3049	162	1	lme4	ORG
fnp-3049	163	1	the ‘nbinom1’	ORG
fnp-3049	166	1	cook	PERSON
fnp-3049	166	2	4/(n-p-1	QUANTITY
fnp-3049	167	1	linear	ORG
fnp-3049	167	2	mm	PERSON
fnp-3049	168	1	zero	CARDINAL
fnp-3049	169	1	+/-10%	PERCENT
fnp-3049	169	2	95%	PERCENT
fnp-3049	170	1	αsyn aggregation	PERSON
fnp-3049	171	1	two	CARDINAL
fnp-3049	171	2	(4.3x1013gc/ml	QUANTITY
fnp-3049	172	1	two	CARDINAL
fnp-3049	172	2	a 4and	CARDINAL
fnp-3049	172	3	6-fold	CARDINAL
fnp-3049	173	1	1a	CARDINAL
fnp-3049	173	2	3b	CARDINAL
fnp-3049	174	1	1.	DATE
fnp-3049	176	1	sn	ORG
fnp-3049	177	1	sn	ORG
fnp-3049	177	2	msdc-0160	DATE
fnp-3049	178	1	500 μm	MONEY
fnp-3049	180	1	0.001, ~22.5%	PERCENT
fnp-3049	181	1	10.3%	PERCENT
fnp-3049	181	2	36.0%	PERCENT
fnp-3049	181	3	8	CARDINAL
fnp-3049	182	1	0.031	CARDINAL
fnp-3049	182	2	14.9%	PERCENT
fnp-3049	182	3	4.8	CARDINAL
fnp-3049	182	4	23.9	CARDINAL
fnp-3049	182	5	0.05	CARDINAL
fnp-3049	182	6	13.4%	PERCENT
fnp-3049	182	7	3.1 22.6	CARDINAL
fnp-3049	182	8	0.0313	CARDINAL
fnp-3049	182	9	15.6%	PERCENT
fnp-3049	182	10	24.55.6	CARDINAL
fnp-3049	183	1	sn	ORG
fnp-3049	184	1	13%	PERCENT
fnp-3049	184	2	0.0001	CARDINAL
fnp-3049	184	3	95%	PERCENT
fnp-3049	184	4	6.4 20.1	CARDINAL
fnp-3049	185	1	αsyn	PERSON
fnp-3049	185	2	0.001	CARDINAL
fnp-3049	185	3	15%	PERCENT
fnp-3049	185	4	8%	PERCENT
fnp-3049	185	5	21%	PERCENT
fnp-3049	185	6	18.4%	PERCENT
fnp-3049	185	7	12.0%	PERCENT
fnp-3049	185	8	24.4%	PERCENT
fnp-3049	185	9	16%	PERCENT
fnp-3049	185	10	22.2%	PERCENT
fnp-3049	185	11	9.3%	PERCENT
fnp-3049	186	1	8 weeks of age	DATE
fnp-3049	186	2	cmv-syn-αsyn	ORG
fnp-3049	186	3	cmv-syn-gfp	ORG
fnp-3049	187	1	1a	CARDINAL
fnp-3049	188	1	one week	DATE
fnp-3049	188	2	msdc-0160	DATE
fnp-3049	188	3	four months	DATE
fnp-3049	189	1	msdc-0160	DATE
fnp-3049	189	2	msdc-0160	DATE
fnp-3049	189	3	20 hours	TIME
fnp-3049	189	4	fig	ORG
fnp-3049	190	1	1	CARDINAL
fnp-3049	191	1	msdc-0160	DATE
fnp-3049	192	1	msdc-0160	DATE
fnp-3049	193	1	1	CARDINAL
fnp-3049	195	1	2a	CARDINAL
fnp-3049	196	1	four-month	DATE
fnp-3049	196	2	msdc-0160	DATE
fnp-3049	197	1	2c	CARDINAL
fnp-3049	198	1	msdc-0160	DATE
fnp-3049	199	1	four months	DATE
fnp-3049	200	1	msdc-0160	DATE
fnp-3049	201	1	3	CARDINAL
fnp-3049	202	1	sn via	ORG
fnp-3049	203	1	1a	CARDINAL
fnp-3049	205	1	mm	PERSON
fnp-3049	205	2	-6.2 mm	PERSON
fnp-3049	206	1	4	CARDINAL
fnp-3049	208	1	fig	ORG
fnp-3049	208	2	2a	CARDINAL
fnp-3049	209	1	msdc-0160	DATE
fnp-3049	209	2	12132	CARDINAL
fnp-3049	209	3	0.002	CARDINAL
fnp-3049	209	4	2b	CARDINAL
fnp-3049	210	1	between msdc-0160	DATE
fnp-3049	211	1	2	CARDINAL
fnp-3049	212	1	sn	ORG
fnp-3049	213	1	sn	ORG
fnp-3049	214	1	450 μm	QUANTITY
fnp-3049	215	1	sn	ORG
fnp-3049	216	1	msdc-0160	DATE
fnp-3049	216	2	0.01	CARDINAL
fnp-3049	216	3	0.001	CARDINAL
fnp-3049	217	1	1%	PERCENT
fnp-3049	217	2	1%	PERCENT
fnp-3049	217	3	msdc-0160	DATE
fnp-3049	217	4	0.046,	PERCENT
fnp-3049	217	5	95%	PERCENT
fnp-3049	217	6	0.039	CARDINAL
fnp-3049	217	7	0.471	CARDINAL
fnp-3049	217	8	6	CARDINAL
fnp-3049	217	9	0.013	CARDINAL
fnp-3049	217	10	95%	PERCENT
fnp-3049	217	11	0.129	CARDINAL
fnp-3049	217	12	0.691	CARDINAL
fnp-3049	217	13	6	CARDINAL
fnp-3049	217	14	1%	PERCENT
fnp-3049	218	1	3e	CARDINAL
fnp-3049	219	1	between msdc-0160	DATE
fnp-3049	220	1	3e	CARDINAL
fnp-3049	221	1	msdc-0160	DATE
fnp-3049	222	1	3	CARDINAL
fnp-3049	223	1	αsyn aggregation	PERSON
fnp-3049	223	2	sn	ORG
fnp-3049	224	1	mpc	ORG
fnp-3049	226	1	αsyn	PERSON
fnp-3049	226	2	a 4and	CARDINAL
fnp-3049	226	3	6-fold	CARDINAL
fnp-3049	227	1	1%	PERCENT
fnp-3049	227	2	1%	PERCENT
fnp-3049	227	3	hu-αsyn	PERSON
fnp-3049	227	4	msdc-0160	DATE
fnp-3049	228	1	mpc	ORG
fnp-3049	228	2	1%	PERCENT
fnp-3049	228	3	1%	PERCENT
fnp-3049	228	4	6	CARDINAL
fnp-3049	228	5	0.05 square-root	QUANTITY
fnp-3049	228	6	6	CARDINAL
fnp-3049	230	1	αsyn	PERSON
fnp-3049	230	2	mitochondria17	ORG
fnp-3049	231	1	mitochondria18	ORG
fnp-3049	232	1	αsyn	PERSON
fnp-3049	232	2	toxicity19	CARDINAL
fnp-3049	233	1	msdc-0160	DATE
fnp-3049	234	1	nitrated ni-αsyn	PERSON
fnp-3049	234	2	ni-αsyn	ORG
fnp-3049	234	3	ni-αsyn	PERSON
fnp-3049	234	4	0.021,	PERCENT
fnp-3049	234	5	95%	PERCENT
fnp-3049	234	6	11.5%	PERCENT
fnp-3049	234	7	111.7%	PERCENT
fnp-3049	234	8	αsyn	GPE
fnp-3049	234	9	4	CARDINAL
fnp-3049	236	1	4	CARDINAL
fnp-3049	237	1	ni-αsyn	PERSON
fnp-3049	237	2	msdc-0160	DATE
fnp-3049	238	1	sn	ORG
fnp-3049	239	1	msdc-0160	DATE
fnp-3049	239	2	0.05	CARDINAL
fnp-3049	240	1	four-month	DATE
fnp-3049	240	2	fig	ORG
fnp-3049	241	1	5a	CARDINAL
fnp-3049	241	2	lamp1	PERSON
fnp-3049	241	3	5c	CARDINAL
fnp-3049	243	1	5	CARDINAL
fnp-3049	245	1	sn	ORG
fnp-3049	246	1	50 μm	CARDINAL
fnp-3049	248	1	sn	ORG
fnp-3049	249	1	iba-1	PERSON
fnp-3049	251	1	mpc	ORG
fnp-3049	251	2	αsyn aggregation	PERSON
fnp-3049	251	3	msdc-0160	DATE
fnp-3049	252	1	12-week-old	DATE
fnp-3049	254	1	one-week	DATE
fnp-3049	254	2	pbs	ORG
fnp-3049	254	3	msdc-0160	DATE
fnp-3049	255	1	6a	CARDINAL
fnp-3049	257	1	5a	CARDINAL
fnp-3049	258	1	5and 13-weeks	DATE
fnp-3049	258	2	msdc-0160	DATE
fnp-3049	258	3	5c	CARDINAL
fnp-3049	259	1	6	CARDINAL
fnp-3049	260	1	aon	GPE
fnp-3049	261	1	12 weeks	DATE
fnp-3049	261	2	c57bl/6j	ORG
fnp-3049	261	3	pbs	ORG
fnp-3049	261	4	one-week	DATE
fnp-3049	261	5	msdc-0160	DATE
fnp-3049	261	6	5or	ORDINAL
fnp-3049	261	7	13-week	DATE
fnp-3049	262	1	aon	GPE
fnp-3049	262	2	5 or 13 weeks	DATE
fnp-3049	262	3	msdc-0160	DATE
fnp-3049	263	1	5 weeks	DATE
fnp-3049	263	2	1.8	CARDINAL
fnp-3049	263	3	95%	PERCENT
fnp-3049	263	4	1.176	CARDINAL
fnp-3049	263	5	2.824	MONEY
fnp-3049	264	1	13-week	DATE
fnp-3049	264	2	95%	PERCENT
fnp-3049	265	1	one and three months of msdc-0160	DATE
fnp-3049	266	1	aon	GPE
fnp-3049	266	2	130 μm	QUANTITY
fnp-3049	266	3	100 μm	CARDINAL
fnp-3049	268	1	13 weeks	DATE
fnp-3049	269	1	pbs	ORG
fnp-3049	269	2	msdc-0160	DATE
fnp-3049	270	1	6a	CARDINAL
fnp-3049	271	1	cv	ORG
fnp-3049	271	2	aon	GPE
fnp-3049	271	3	13 weeks	DATE
fnp-3049	272	1	6b	CARDINAL
fnp-3049	273	1	5and 13-weeks	DATE
fnp-3049	273	2	aon	GPE
fnp-3049	273	3	8.5-16	CARDINAL
fnp-3049	274	1	6b	CARDINAL
fnp-3049	275	1	65-78%	PERCENT
fnp-3049	276	1	5 to 13 weeks	DATE
fnp-3049	276	2	msdc-0160	DATE
fnp-3049	276	3	~99.2%	PERCENT
fnp-3049	276	4	163.2%	PERCENT
fnp-3049	276	5	week 5 to week 13	DATE
fnp-3049	276	6	aon	ORG
fnp-3049	276	7	0.016	CARDINAL
fnp-3049	276	8	0.001	CARDINAL
fnp-3049	276	9	95%	PERCENT
fnp-3049	277	1	19.2 233.3	CARDINAL
fnp-3049	277	2	55.8 344.4	CARDINAL
fnp-3049	278	1	aon	GPE
fnp-3049	278	2	5 to 13	CARDINAL
fnp-3049	278	3	95%	PERCENT
fnp-3049	278	4	18.3%	PERCENT
fnp-3049	278	5	200%	PERCENT
fnp-3049	279	1	msdc-0160	DATE
fnp-3049	280	1	msdc-0160	DATE
fnp-3049	280	2	5 weeks	DATE
fnp-3049	280	3	1.8	CARDINAL
fnp-3049	280	4	95%	PERCENT
fnp-3049	280	5	1.16 2.90	CARDINAL
fnp-3049	281	1	13-week	DATE
fnp-3049	281	2	95%	PERCENT
fnp-3049	281	3	0.98-1.95	CARDINAL
fnp-3049	282	1	ni-αsyn	PERSON
fnp-3049	282	2	13-week	DATE
fnp-3049	283	1	7	CARDINAL
fnp-3049	285	1	lcos	PERSON
fnp-3049	285	2	fluorescent21	LOC
fnp-3049	286	1	one	CARDINAL
fnp-3049	286	2	aon	GPE
fnp-3049	286	3	13 weeks	DATE
fnp-3049	287	1	7	CARDINAL
fnp-3049	290	1	αsyn assembly	GPE
fnp-3049	290	2	several weeks	DATE
fnp-3049	290	3	two	CARDINAL
fnp-3049	291	1	7	CARDINAL
fnp-3049	292	1	aon	GPE
fnp-3049	292	2	sn	ORG
fnp-3049	293	1	aon	GPE
fnp-3049	293	2	13 weeks	DATE
fnp-3049	294	1	dapi	PERSON
fnp-3049	294	2	10 μm and 3	CARDINAL
fnp-3049	295	1	aon	GPE
fnp-3049	295	2	13 weeks	DATE
fnp-3049	297	1	8a	CARDINAL
fnp-3049	298	1	pbs	ORG
fnp-3049	298	2	msdc-0160	DATE
fnp-3049	299	1	lamp2	ORG
fnp-3049	299	2	aon	GPE
fnp-3049	299	3	13 weeks	DATE
fnp-3049	300	1	8c	CARDINAL
fnp-3049	302	1	8	CARDINAL
fnp-3049	303	1	13-weeks	DATE
fnp-3049	304	1	aon	GPE
fnp-3049	304	2	50 μm	CARDINAL
fnp-3049	305	1	5	CARDINAL
fnp-3049	306	1	lamp2	ORG
fnp-3049	306	2	aon	GPE
fnp-3049	307	1	dapi	PERSON
fnp-3049	308	1	10 μm	QUANTITY
fnp-3049	308	2	lamp2	ORG
fnp-3049	308	3	pd.	GPE
fnp-3049	310	1	msdc-0160	DATE
fnp-3049	310	2	2	CARDINAL
fnp-3049	310	3	1-methyl-4-phenyl-1,2,3,6	QUANTITY
fnp-3049	310	4	engrailed1+/-	NORP
fnp-3049	310	5	mpc	ORG
fnp-3049	311	1	msdc-0160	DATE
fnp-3049	311	2	two	CARDINAL
fnp-3049	311	3	pd.	GPE
fnp-3049	312	1	first	ORDINAL
fnp-3049	312	2	sn	ORG
fnp-3049	313	1	four months	DATE
fnp-3049	313	2	msdc-0160	DATE
fnp-3049	314	1	second	ORDINAL
fnp-3049	315	1	five weeks	DATE
fnp-3049	315	2	msdc-0160	DATE
fnp-3049	316	1	the later	DATE
fnp-3049	316	2	13-week	DATE
fnp-3049	316	3	two	CARDINAL
fnp-3049	317	1	the αsyn viral vector	ORG
fnp-3049	317	2	the αsyn pff	ORG
fnp-3049	319	1	several weeks	DATE
fnp-3049	319	2	two	CARDINAL
fnp-3049	320	1	two	CARDINAL
fnp-3049	321	1	αsyn assembly	GPE
fnp-3049	322	1	first	ORDINAL
fnp-3049	323	1	ros	CARDINAL
fnp-3049	325	1	msdc-0160	DATE
fnp-3049	328	1	αsyn	GPE
fnp-3049	328	2	function23	NORP
fnp-3049	329	1	mitochondria18	ORG
fnp-3049	330	1	αsyn24	ORG
fnp-3049	330	2	stress25	DATE
fnp-3049	331	1	αsyn	PERSON
fnp-3049	331	2	sn	ORG
fnp-3049	331	3	αsyn27	PERSON
fnp-3049	332	1	msdc-0160	DATE
fnp-3049	332	2	sn	ORG
fnp-3049	334	1	lco h	GPE
fnp-3049	334	2	probe29	GPE
fnp-3049	335	1	lcos	PERSON
fnp-3049	337	1	diseases21	GPE
fnp-3049	340	1	two	CARDINAL
fnp-3049	340	2	the αsyn assembly	ORG
fnp-3049	341	1	gómez-benito	ORG
fnp-3049	341	2	aav	PRODUCT
fnp-3049	341	3	structures31	ORG
fnp-3049	342	1	msdc-0160	DATE
fnp-3049	343	1	mpc	ORG
fnp-3049	344	1	msdc-0160	DATE
fnp-3049	345	1	msdc-0160	DATE
fnp-3049	345	2	vivo10	PRODUCT
fnp-3049	348	1	42-40384-1	DATE
fnp-3049	349	1	w.p.	PERSON
fnp-3049	349	2	fulbright	ORG
fnp-3049	350	1	van andel institute	ORG
fnp-3049	352	1	l.b.	GPE
fnp-3049	352	2	ni-αsyn	PERSON
fnp-3049	352	3	lamp2	ORG
fnp-3049	353	1	aav	PRODUCT
fnp-3049	356	1	j.s.	PERSON
fnp-3049	356	2	msdc-0160	DATE
fnp-3049	357	1	l.m.	ORG
fnp-3049	359	1	z.m.	GPE
fnp-3049	360	1	j.m.	PERSON
fnp-3049	361	1	k.b	PERSON
fnp-3049	363	1	p.b.	PERSON
fnp-3049	365	1	calico life sciences	ORG
fnp-3049	365	2	idorsia	ORG
fnp-3049	366	1	roche	ORG
fnp-3049	367	1	acousort ab. j.r.c.	PERSON
fnp-3049	368	1	msdc-0160	DATE
fnp-3049	369	1	msdc-0160	DATE
fnp-3049	369	2	8389556	DATE
fnp-3049	369	3	2001468	CARDINAL
fnp-3049	369	4	msdc	ORG
fnp-3049	371	1	1	CARDINAL
fnp-3049	371	2	m. b.	PERSON
fnp-3049	371	3	lang, a. & poewe	ORG
fnp-3049	371	4	w. toward	PERSON
fnp-3049	372	1	mov disord	PERSON
fnp-3049	373	1	27	CARDINAL
fnp-3049	373	2	54–60	CARDINAL
fnp-3049	373	3	2012	DATE
fnp-3049	374	1	2	CARDINAL
fnp-3049	374	2	davis	PERSON
fnp-3049	374	3	r. l. & sue	ORG
fnp-3049	374	4	c. m. mitochondrial dysfunction	PERSON
fnp-3049	375	1	1–11	CARDINAL
fnp-3049	375	2	2018	DATE
fnp-3049	376	1	b. et	PERSON
fnp-3049	377	1	glitazone	PERSON
fnp-3049	378	1	mov disord	PERSON
fnp-3049	379	1	54	DATE
fnp-3049	379	2	2017	CARDINAL
fnp-3049	380	1	4	CARDINAL
fnp-3049	380	2	brauer	PERSON
fnp-3049	380	3	r. et al	PERSON
fnp-3049	380	4	glitazone	PERSON
fnp-3049	381	1	plos med 12, e1001854–16	PERSON
fnp-3049	381	2	2015	CARDINAL
fnp-3049	382	1	5	CARDINAL
fnp-3049	382	2	biosa	PERSON
fnp-3049	382	3	a.	PERSON
fnp-3049	382	4	outeiro	PERSON
fnp-3049	382	5	t. f.	PERSON
fnp-3049	382	6	l. & bisaglia	ORG
fnp-3049	383	1	1–10	CARDINAL
fnp-3049	383	2	2018	DATE
fnp-3049	385	1	athauda	NORP
fnp-3049	386	1	d. et al	PERSON
fnp-3049	386	2	weekly	DATE
fnp-3049	387	1	390	CARDINAL
fnp-3049	387	2	1664–1675	CARDINAL
fnp-3049	387	3	2017	CARDINAL
fnp-3049	388	1	7	CARDINAL
fnp-3049	388	2	athauda	NORP
fnp-3049	388	3	d. et al	PERSON
fnp-3049	390	1	8	CARDINAL
fnp-3049	390	2	247–258	DATE
fnp-3049	390	3	2018	DATE
fnp-3049	391	1	8	CARDINAL
fnp-3049	392	1	2	CARDINAL
fnp-3049	393	1	14	DATE
fnp-3049	393	2	795–803	DATE
fnp-3049	393	3	2015	CARDINAL
fnp-3049	394	1	chen	PERSON
fnp-3049	394	2	z. et al	PERSON
fnp-3049	395	1	j. biol	PERSON
fnp-3049	397	1	287	CARDINAL
fnp-3049	397	2	23537–23548	CARDINAL
fnp-3049	397	3	2012	DATE
fnp-3049	398	1	10	CARDINAL
fnp-3049	399	1	a. et al	PERSON
fnp-3049	401	1	2016	CARDINAL
fnp-3049	402	1	11	CARDINAL
fnp-3049	403	1	l. et al	PERSON
fnp-3049	403	2	engrailed1	DATE
fnp-3049	404	1	j. neurosci	PERSON
fnp-3049	405	1	27, 1063–1071 (	DATE
fnp-3049	405	2	2007	DATE
fnp-3049	406	1	12	CARDINAL
fnp-3049	406	2	becker	PERSON
fnp-3049	406	3	k. et al	PERSON
fnp-3049	407	1	msa	ORG
fnp-3049	408	1	55	DATE
fnp-3049	408	2	1–10	CARDINAL
fnp-3049	408	3	2018	DATE
fnp-3049	409	1	13	CARDINAL
fnp-3049	409	2	george, s. et al	PERSON
fnp-3049	411	1	14	DATE
fnp-3049	411	2	1–22	CARDINAL
fnp-3049	411	3	2019	CARDINAL
fnp-3049	412	1	14	CARDINAL
fnp-3049	413	1	van der perren	PERSON
fnp-3049	413	2	a. et al	PERSON
fnp-3049	414	1	jove 1–8 (	ORG
fnp-3049	414	2	2016	DATE
fnp-3049	416	1	colca	PERSON
fnp-3049	416	2	j. r. et al	PERSON
fnp-3049	417	1	msdc-0160	DATE
fnp-3049	418	1	clin pharmacol	ORG
fnp-3049	418	2	93	CARDINAL
fnp-3049	418	3	352–359	CARDINAL
fnp-3049	418	4	2013	DATE
fnp-3049	419	1	16	CARDINAL
fnp-3049	420	1	johnson	PERSON
fnp-3049	420	2	m. e. et al	PERSON
fnp-3049	421	1	1–13	CARDINAL
fnp-3049	421	2	2020	DATE
fnp-3049	422	1	doi:10.1038	ORG
fnp-3049	422	2	di maio	PERSON
fnp-3049	422	3	r. et al	PERSON
fnp-3049	424	1	8	CARDINAL
fnp-3049	424	2	342ra78–342ra78	CARDINAL
fnp-3049	424	3	2016	CARDINAL
fnp-3049	425	1	18	CARDINAL
fnp-3049	425	2	ryan	PERSON
fnp-3049	425	3	t. et al	PERSON
fnp-3049	425	4	cardiolipin	PERSON
fnp-3049	426	1	1–17	CARDINAL
fnp-3049	426	2	2018	DATE
fnp-3049	427	1	doi:10.1038	ORG
fnp-3049	427	2	winklhofer, k. f. & haass	PERSON
fnp-3049	428	1	1802	DATE
fnp-3049	428	2	29–44	CARDINAL
fnp-3049	428	3	2010	DATE
fnp-3049	429	1	20	CARDINAL
fnp-3049	429	2	rey	PERSON
fnp-3049	429	3	n. l. et al	PERSON
fnp-3049	431	1	213	CARDINAL
fnp-3049	431	2	2016	CARDINAL
fnp-3049	432	1	21	CARDINAL
fnp-3049	432	2	klingstedt	GPE
fnp-3049	432	3	t. et al	PERSON
fnp-3049	433	1	biomol	PERSON
fnp-3049	435	1	9, 8356–25 (	PERCENT
fnp-3049	435	2	2011	DATE
fnp-3049	436	1	22	CARDINAL
fnp-3049	437	1	cheong	PERSON
fnp-3049	437	2	j. l. y.	PERSON
fnp-3049	437	3	de pablo-fernandez	PERSON
fnp-3049	437	4	e.	PERSON
fnp-3049	437	5	t. & noyce	ORG
fnp-3049	437	6	a. j. the association	PERSON
fnp-3049	437	7	2	CARDINAL
fnp-3049	438	1	10	CARDINAL
fnp-3049	438	2	775–789	CARDINAL
fnp-3049	438	3	2020	DATE
fnp-3049	439	1	23	CARDINAL
fnp-3049	440	1	w. & baekelandt	ORG
fnp-3049	441	1	j. neurochem	PERSON
fnp-3049	442	1	256–274	CARDINAL
fnp-3049	442	2	2016	CARDINAL
fnp-3049	443	1	24	CARDINAL
fnp-3049	443	2	c. et al	PERSON
fnp-3049	444	1	nat chem biol 11	ORG
fnp-3049	444	2	229–234	CARDINAL
fnp-3049	444	3	2015	CARDINAL
fnp-3049	445	1	25	CARDINAL
fnp-3049	446	1	parihar	PERSON
fnp-3049	446	2	m. s.	PERSON
fnp-3049	446	3	parihar	PERSON
fnp-3049	446	4	fujita	ORG
fnp-3049	446	5	m.	PERSON
fnp-3049	446	6	m. & ghafourifar	ORG
fnp-3049	448	1	sci. 65,	ORG
fnp-3049	448	2	1272–1284	DATE
fnp-3049	449	1	26	CARDINAL
fnp-3049	449	2	rocha	PERSON
fnp-3049	449	3	e. m.	PERSON
fnp-3049	449	4	de miranda	PERSON
fnp-3049	449	5	b. & sanders	ORG
fnp-3049	449	6	l. h. alpha-synuclein	PERSON
fnp-3049	450	1	109	CARDINAL
fnp-3049	450	2	249–257	CARDINAL
fnp-3049	450	3	2018	DATE
fnp-3049	451	1	27	CARDINAL
fnp-3049	451	2	z. et al	PERSON
fnp-3049	453	1	plos	PERSON
fnp-3049	453	2	one 5	DATE
fnp-3049	453	3	2010	DATE
fnp-3049	454	1	28	CARDINAL
fnp-3049	455	1	uversky	PERSON
fnp-3049	455	2	n. et al	PERSON
fnp-3049	456	1	134	CARDINAL
fnp-3049	456	2	2005	DATE
fnp-3049	457	1	29	CARDINAL
fnp-3049	457	2	h. et al	PERSON
fnp-3049	461	1	j. 21	PERSON
fnp-3049	461	2	15133–15137	CARDINAL
fnp-3049	461	3	2015	CARDINAL
fnp-3049	462	1	30	CARDINAL
fnp-3049	463	1	shahnawaz	PERSON
fnp-3049	463	2	m. et al	PERSON
fnp-3049	465	1	2020	DATE
fnp-3049	466	1	doi:10.1038	ORG
fnp-3049	466	2	020	CARDINAL
fnp-3049	466	3	7 31	DATE
fnp-3049	467	1	gómez-benito	ORG
fnp-3049	467	2	m. et al	PERSON
fnp-3049	471	1	11	CARDINAL
fnp-3049	471	2	1–15	CARDINAL
fnp-3049	471	3	2020	DATE
fnp-3049	472	1	2020	DATE
fnp-3049	473	1	4.0	CARDINAL
fnp-3049	473	2	https://creativecommons.org/licenses/by/4.0/	WORK_OF_ART